BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34814273)

  • 1. Identification of prognostic hypoxia-related genes signature on the tumor microenvironment in esophageal cancer.
    Tan L; Cheng D; Wen J; Huang K; Zhang Q
    Math Biosci Eng; 2021 Sep; 18(6):7743-7758. PubMed ID: 34814273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Hypoxia in Intestinal Tumors on Immune Cell Behavior in the Tumor Microenvironment.
    Zhang L; Wang S; Wang Y; Zhao W; Zhang Y; Zhang N; Xu H
    Front Immunol; 2021; 12():645320. PubMed ID: 33737938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a risk model by integrating hypoxia genes in predicting prognosis of esophageal squamous cell carcinoma.
    Xiao W; Tang P; Sui Z; Han Y; Zhao G; Wu X; Yang Y; Zhu N; Gong L; Yu Z; Zhang H
    Cancer Med; 2023 Jan; 12(2):2117-2133. PubMed ID: 35789548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
    Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
    Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress genes in patients with esophageal squamous cell carcinoma: construction of a novel prognostic signature and characterization of tumor microenvironment infiltration.
    Liu W; Yang HS; Zheng SY; Luo HH; Feng YF; Lei YY
    BMC Bioinformatics; 2022 Sep; 23(1):406. PubMed ID: 36180848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Liu M; Li F; Liu B; Jian Y; Zhang D; Zhou H; Wang Y; Xu Z
    BMC Med Genomics; 2021 Mar; 14(1):75. PubMed ID: 33691689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.
    Hu X; Wu L; Liu B; Chen K
    Front Immunol; 2021; 12():651056. PubMed ID: 34122409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
    Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
    Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative genome-scale analysis of immune infiltration in esophageal carcinoma.
    Bian Y; Bi G; Wei T; Yao G; Chen Z; Zhan C; Fan H
    Int Immunopharmacol; 2021 Apr; 93():107371. PubMed ID: 33535118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated bioinformatics analysis of differentially expressed genes and immune cell infiltration characteristics in Esophageal Squamous cell carcinoma.
    Feng Z; Qu J; Liu X; Liang J; Li Y; Jiang J; Zhang H; Tian H
    Sci Rep; 2021 Aug; 11(1):16696. PubMed ID: 34404882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and Verification of a Hypoxia-Stemness-Based Gene Signature for Risk Stratification in Esophageal Cancer.
    Tang K; Cheng Y; Li Q
    Med Sci Monit; 2021 Oct; 27():e934359. PubMed ID: 34716287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of hypoxia signature to predict prognosis and the tumor immune microenvironment in melanoma.
    Shou Y; Yang L; Yang Y; Zhu X; Li F; Xu J
    Mol Omics; 2021 Apr; 17(2):307-316. PubMed ID: 33624645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of the prognostic value of immune gene signature and infiltrating immune cells for esophageal cancer patients.
    Wang L; Wei Q; Zhang M; Chen L; Li Z; Zhou C; He M; Wei M; Zhao L
    Int Immunopharmacol; 2020 Oct; 87():106795. PubMed ID: 32707495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.
    Jesinghaus M; Steiger K; Slotta-Huspenina J; Drecoll E; Pfarr N; Meyer P; Konukiewitz B; Bettstetter M; Wieczorek K; Ott K; Feith M; Langer R; Weichert W; Specht K; Boxberg M
    Oncotarget; 2017 Jul; 8(29):46756-46768. PubMed ID: 28657901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A signature of tumor immune microenvironment genes associated with the prognosis of non‑small cell lung cancer.
    Li J; Li X; Zhang C; Zhang C; Wang H
    Oncol Rep; 2020 Mar; 43(3):795-806. PubMed ID: 32020214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.